The stock tanked 5.65 per cent to end at Rs 1,160 on BSE. Intra-day, it lost 9.63 per cent to Rs 1,111.
On NSE, it declined 4.87 per cent to close at Rs 1,161.50.
Drug firm Divis Laboratories on Saturday reported a 24.60 per cent slump in standalone net profit to Rs 223.85 crore for the quarter ended September, mainly on account of increased expenses.
The company had posted a net profit from ordinary activities after tax of Rs 296.90 crore during the same period of last fiscal, Divis Laboratories said in a BSE filing.
Disclaimer: No Business Standard Journalist was involved in creation of this content
